The Complete FDA Compliance Guide for Peptide Marketing in 2026

In the last 18 months, the FDA has issued more warning letters to peptide and supplement companies than in the previous five years combined. The FTC has ramped up enforcement of unsubstantiated health claims. Google and Meta have tightened their healthcare advertising policies. And payment processors are flagging supplement merchants at unprecedented rates.

If you are marketing peptides, research compounds, or dietary supplements online, compliance is no longer a nice-to-have. It is the foundation that everything else sits on. Get it wrong and you lose your ability to advertise, process payments, and ultimately operate.

This guide is the compliance framework we use at BioHack Agency for every peptide and supplement client. It covers FDA regulations, FTC advertising rules, platform-specific policies, payment processor risk, and exactly what to do if enforcement action hits your brand.

The Fundamental Rule: Structure-Function Claims vs. Drug Claims

The single most important distinction in supplement marketing is the difference between a structure-function claim and a drug claim. Get this wrong and nothing else matters because you have made your product an unapproved drug in the eyes of the FDA.

Under the Dietary Supplement Health and Education Act (DSHEA) of 1994 and as codified in 21 CFR 101.93, dietary supplement companies are permitted to make claims about how their product affects the structure or function of the body. They are not permitted to claim that their product diagnoses, treats, cures, mitigates, or prevents any disease.

Five Compliant Structure-Function Claims

1. "Supports healthy joint function." This describes an effect on body structure without referencing a disease state like arthritis.
2. "Helps maintain a healthy immune response." Maintaining normal function is permissible. Treating immune deficiency is not.
3. "Promotes restful sleep." Sleep quality is a body function. Treating insomnia (a diagnosable condition) would be a drug claim.
4. "Supports muscle recovery after exercise." Post-exercise recovery describes a normal body process, not treatment of an injury.
5. "Helps maintain cognitive function as part of a healthy lifestyle." Cognitive function is structure-function. Preventing Alzheimer's is a drug claim.

Five Non-Compliant Drug Claims

1. "Reduces inflammation." Inflammation is associated with disease states. This implies treatment of a condition.
2. "Treats joint pain." The word "treats" automatically makes this a drug claim. Pain associated with a condition is a disease reference.
3. "Cures insomnia." Any use of "cures" paired with a diagnosable condition is a direct drug claim.
4. "Prevents cognitive decline." Disease prevention language is reserved for FDA-approved drugs only.
5. "Clinically proven to lower cortisol levels." While cortisol is a biomarker, "clinically proven" combined with a specific measurable outcome implies drug-like efficacy.

The line between these two categories is often thinner than brands realize. The FDA evaluates claims in context, meaning the combination of your product name, imagery, claims, testimonials, and even the conditions discussed in surrounding blog content can collectively create an implied drug claim even if no single element crosses the line on its own.

20 Phrases That Will Get Your Peptide Brand in Trouble

We have reviewed hundreds of peptide and supplement brand websites, ad accounts, and product listings. These are the phrases that consistently trigger FDA warning letters, ad disapprovals, and payment processor flags, along with compliant alternatives you can use instead.

The pattern to remember: Replace action verbs that imply treatment (treats, cures, heals, fixes, reverses, eliminates, kills) with support language (supports, promotes, helps maintain, contributes to). Replace disease states with body systems and normal functions.

FTC Advertising Rules for Supplement Brands

The FDA governs labeling and product claims. The FTC governs advertising. Both can take enforcement action against your brand, and they coordinate regularly on supplement industry cases. Here are the three core FTC requirements every peptide and supplement brand must follow.

Substantiation Requirement

The FTC requires that all advertising claims be truthful and backed by competent and reliable scientific evidence before the claim is made. This means you need the evidence in hand before you run the ad, not after someone challenges you.

For health-related claims, the FTC generally expects at least one well-designed, randomized controlled trial (RCT) that tests the specific product or a materially similar formulation. Citing a study on a single ingredient in your blend is usually insufficient if the study used a different dosage, delivery method, or population than your product targets.

Testimonial and Review Rules

Customer testimonials are powerful marketing assets, but the FTC has specific rules about how they can be used. As of the updated FTC Endorsement Guides, testimonials must reflect the typical experience of users, not exceptional results. If you feature a testimonial about dramatic results, you must clearly and prominently disclose what the generally expected results are.

You cannot cherry-pick your best testimonials and present them as representative. If 95% of your customers see modest improvements and 5% see dramatic results, featuring only the dramatic results without qualification is deceptive advertising.

Outcome Claims and Specificity

The more specific your claim, the higher the substantiation burden. Saying "supports energy levels" requires less evidence than "increases energy by 40% in two weeks." Quantified claims, timeframe claims, and comparison claims all require specific evidence that matches the exact claim being made.

Our recommendation: keep claims general enough to be substantiated by the existing body of research on your ingredients, but specific enough to be meaningful to your target customer. The sweet spot is structure-function language paired with ingredient transparency.

Platform-Specific Compliance for Peptide Advertising

Each advertising platform has its own healthcare and supplement policies layered on top of FDA and FTC requirements. A claim that is technically FDA-compliant can still get disapproved on Google or Meta if it violates their platform-specific rules.

Google Ads

Google's healthcare and medicines policy restricts advertising for products that contain certain substances. Peptides are in a gray area: some peptide products are allowed under supplement advertising, while others (particularly those marketed as research chemicals or injectable compounds) may be flagged as unapproved pharmaceuticals.

Key rules for Google Ads compliance:

• Never reference injection, reconstitution, or dosing protocols in ad copy or landing pages that receive ad traffic
• Do not use peptide-specific names like BPC-157, TB-500, or GHK-Cu in ad headlines. Use them only in educational content that is not directly linked to purchase
• Landing pages must include the structure-function disclaimer, a clear terms of service, and a privacy policy
• Apply for Google's Healthcare Advertiser Certification if running any supplement-adjacent campaigns
• Keep ad copy focused on benefits (supports recovery, promotes wellness) rather than mechanisms (stimulates growth hormone release)

Meta (Facebook and Instagram)

Meta's advertising policies prohibit before-and-after images for health products, claims of specific results, and any content that implies personal health attributes. This is more restrictive than FDA guidelines.

What works on Meta for supplement brands:

• Educational content that discusses ingredient research without making product-specific claims
• Lifestyle imagery that does not imply before-and-after transformation
• Social proof through engagement metrics rather than testimonial-focused ad creative
• Landing pages that separate educational content from purchase pathways

YouTube

YouTube follows Google's advertising policies but also applies content policies to organic videos. Videos that discuss peptides in a medical context may be demonetized or restricted. Sponsored content and affiliate links in peptide-related videos must include clear FTC disclosures.

TikTok

TikTok prohibits advertising for most supplement categories. Organic content about supplements and peptides is permitted but subject to community guideline enforcement that can be inconsistent. Avoid making any health claims in TikTok content, even in organic posts, as violations can result in account suspension.

Payment Processor Risk

This is the compliance issue that catches the most brands off guard. Even if your marketing is perfectly compliant with FDA, FTC, and platform rules, your payment processor can freeze your funds or terminate your account if they classify your business as high-risk.

Why Supplement Brands Get Flagged

Payment processors like Stripe, Square, and PayPal categorize merchants using Merchant Category Codes (MCC). Supplement and nutraceutical businesses often fall into MCC 5912 (Drug Stores and Pharmacies) or MCC 5499 (Miscellaneous Food Stores), both of which carry higher fraud and chargeback risk profiles.

Peptide companies face additional scrutiny because the products sit at the intersection of supplements and pharmaceuticals. Processors do not always distinguish between a legitimate supplement brand selling capsules and a gray-market vendor selling injectable research peptides.

How to Protect Your Payment Processing

• Be transparent in your merchant application. Describe your products accurately. Do not downplay the supplement nature of your business to avoid classification issues.
• Maintain chargeback rates below 1%. This is the single most important metric for processor relationships. Invest in clear product descriptions, realistic delivery timelines, and responsive customer service.
• Have compliant product pages. Processors review your website. If they find drug claims, before-and-after images, or misleading testimonials, they will flag your account regardless of your chargeback rate.
• Use a supplement-friendly processor. Consider processors that specialize in nutraceuticals and high-risk verticals. They understand the industry and are less likely to flag legitimate operations.
• Keep separate checkout flows for research-use products. If you sell both consumer supplements and research-use compounds, maintain clearly separated storefronts with appropriate disclaimers on each.

The Structure-Function Disclaimer

If you make any structure-function claims on your product labeling or website, you are legally required to include the following disclaimer:

"These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease."

This disclaimer is required by DSHEA and must appear on the product label and on any webpage where structure-function claims are made. It is not optional, it is not a suggestion, and it does not protect you from enforcement if your actual claims are non-compliant.

Placement Requirements

The disclaimer must be prominent, conspicuous, and proximate to the claims it accompanies. Burying it in a footer that requires scrolling past three screens of product claims does not satisfy the requirement. Best practice is to place the disclaimer directly below any structure-function claims and in a font size no smaller than the claims themselves.

Common Mistakes

• Using the disclaimer as a shield for drug claims. The disclaimer does not make non-compliant claims compliant. You cannot say "cures cancer" and then add the FDA disclaimer. The claim itself must be a valid structure-function claim.
• Only placing it on the product label but not the website. If your website makes structure-function claims, the disclaimer must appear on those pages.
• Making the disclaimer text too small or low-contrast. If it is not legible, it does not count.
• Forgetting to include it on social media product posts. Any post that makes structure-function claims should include the disclaimer or a link to it.

What to Do If You Receive an FDA Warning Letter

An FDA warning letter is not a fine, a lawsuit, or a shutdown order. It is a formal notification that the FDA has identified violations and expects you to correct them. However, how you respond determines whether the situation resolves quietly or escalates to injunctions, seizures, or consent decrees.

Step 1: Do Not Panic, But Act Immediately

You have 15 business days from receipt to respond to the FDA. This timeline is firm. Start working on your response the day the letter arrives.

Step 2: Hire a Regulatory Attorney

Do not attempt to respond to an FDA warning letter without legal counsel experienced in FDA enforcement. The cost of an attorney is negligible compared to the cost of a botched response that leads to escalated enforcement.

Step 3: Audit Every Claim Across All Channels

The warning letter will cite specific violations, but the FDA expects you to audit and correct all non-compliant claims, not just the ones they identified. Review every product page, ad campaign, social media post, email sequence, and piece of printed marketing material.

Step 4: Make Corrections Before You Respond

Your response letter should detail the specific corrections you have already made, not the corrections you plan to make. The FDA wants to see completed action, not promises.

Step 5: Implement Ongoing Compliance Review

Include in your response a description of the compliance processes you are implementing to prevent future violations. This shows the FDA that you are treating this as a systemic issue, not a one-time mistake.

Step 6: Monitor for Follow-Up

The FDA may conduct a follow-up inspection or review your website again after your response. Ensure that all corrections are maintained and that no new violations have been introduced.

Critical note: Warning letters are public record and are published on the FDA website. Potential customers, competitors, partners, and payment processors can see them. A clean response that resolves the matter quickly limits the reputational damage.

Compliance is not a constraint on your marketing. It is the infrastructure that allows your marketing to operate at scale without interruption. The brands that build compliance into their marketing process from the start are the ones that still have functioning ad accounts, active payment processors, and clean regulatory records when their competitors are scrambling to recover from enforcement actions.

If you want a professional compliance audit of your current marketing, use our free brand scan tool to get an initial assessment, download our compliance checklist for a step-by-step framework, or book a discovery call to discuss your specific situation with our team.